https://www.rometx.com/ | United States | 2020 | $127M
ROME Therapeutics is a biotechnology company developing therapies for cancer and autoimmune diseases by leveraging the repeatome, which is the vast stretches of uncharted genetic material that have been previously dismissed as “junk DNA”. The company has assembled a team of experts across various fields to lead this exploration of the repeatome and identify new drug targets.
